Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
COYA Coya Therapeutics
Post Mkt Price
Do not show
Hide blank lines
Total revenue
0 0
Operating revenue
-- 0 -- 0
Cost of revenue
Gross profit
Operating expense
4.87M 1.6M
Selling and administrative expenses
-- 2.31M -- 732.15K
-General and administrative expense
-- 2.31M -- 732.15K
Research and development costs
-- 2.54M -- 855.81K
Depreciation amortization depletion
-- 16.13K -- 10.19K
-Depreciation and amortization
-- 16.13K -- 10.19K
Operating profit
-4.87M -1.6M
Net non-operating interest income expense
Non-operating interest expense
-- 0 -- --
Other net income (expense)
-21.48K -31.53K
Other non- operating income (expenses)
-- -21.48K -- -31.53K
Income before tax
-4.89M -1.63M
Income tax
Net income
-4.89M -1.63M
Net income continuous Operations
-- -4.89M -- -1.63M
Minority interest income
Net income attributable to the parent company
-4.89M -1.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-4.91M -1.65M
Basic earnings per share
-1.26 -0.2494
Diluted earnings per share
-1.26 -0.2494
Dividend per share
Currency Unit
Audit Opinions
Unqualified Opinion with Explanation--

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
CEO: Dr. Howard Berman, PhD
Market: NASDAQ
Listing Date: 12/29/2022
Futu Hot List
SymbolLatest price%Chg